$3.5 million for Siemens Institute for
WINNIPEG – The Winnipeg Partnership Agreement is
making a $3.5 million investment towards the construction of the Siemens
Institute for Advanced Medicine at the Health Sciences Centre in
Winnipeg. The contribution is aimed at fostering better detection and
treatment of illnesses.
The Honourable Vic Toews, Minister of Justice and Attorney General of
Canada, the Honourable Dave Chomiak, Manitoba Minister of Energy,
Science and Technology and Deputy Mayor Mike Pagtakhan, City of
Winnipeg, made the announcement in July.
“Better healthcare for Canadians is a priority of the Government of
Canada,” said Toews, on behalf of the Honourable Carol Skelton, Minister
of National Revenue and Minister of Western Economic Diversification.
“Advanced medical research produces new technologies to deliver quality,
innovative and efficient healthcare.”
“This institute will conduct research to help prevent the spread of
infectious diseases, and discover improved methods of neurosurgery and
advances in neurological sciences,” said Chomiak, on behalf of the
Honourable Scott Smith, Minister of Intergovernmental Affairs and Trade.
“This is a good fit with Manitoba’s commitment to research and
development, preventative medicine and our growing role as a centre for
innovative research in the health and technology fields.”
“Investments such as this one are important to the City of Winnipeg.
They provide valuable research; they attract highly skilled individuals
and research dollars to our city, and most importantly, they provide
huge health benefits,” said Pagtakhan. “We are pleased to be a partner
in this endeavour.”
The Siemens Institute of Advanced Medicine is expected to employ up to
300 highly skilled individuals and attract as much as $30 million
annually in research and development funding.
“We have already begun to see the impact of the Siemens Institute with
the recruitment of a number of new clinical and scientific leaders whose
programs will be in the new institute,” said Dr. Brock Wright, Chief
Operating Officer of the Health Sciences Centre. “By providing the space
and innovative technology they will have the tools to conduct advanced
clinical research for the benefit of all Manitobans.”
Construction is scheduled to begin in fall 2006. The Health Sciences
Centre Foundation has committed to raising $10.5 million from the
community toward capital costs.
Funding for the project comes from Component IV of the Winnipeg
Partnership Agreement. This component is designed to strengthen
Winnipeg’s innovation system by supporting projects that increase the
awareness, capacity and use of new technologies. Component IV will also
build the necessary infrastructure to promote growth in knowledge-based
sectors, such as aerospace, life sciences and alternative energy.
The Winnipeg Partnership Agreement was signed in May 2004 and represents
a five-year, $75-million commitment by the governments of Canada,
Manitoba and Winnipeg to strengthen city neighbourhoods, promote
economic development and enable Aboriginal citizens to fully enjoy
Winnipeg’s economic and social opportunities. For program details,
Clinical research and the delivery of treatment at the Siemens Institute
for Advanced Medicine will be centered on four themes: Medicine,
Surgery, Medical Imaging, and Medical Informatics.
The Institute will investigate advances in technology in the areas of
infectious diseases, neurological sciences and neurosurgery. Researchers
will explore advanced surgical techniques, while promoting new
discoveries in healthcare treatment and education. They will collect
patient data to be able to identify areas of change and assess the
effectiveness and the impact of change due to treatment. Patient safety
is therefore improved and resources are better managed.
The Institute will use medical imaging technology such as the Gamma
Knife, Positron Emission Tomography/Computerised (Axial) Tomography(PET/CT)
scanning, and Magnetic Resonance Imaging, all diagnostic tools used to
identify and/or treat illnesses. For example, the Gamma Knife can be
used to treat selected malignant tumors that arise in or spread to the
brain and the PET scanner can be used to determine blood flow to the
heart muscle and help evaluate signs of coronary artery disease.
The Institute will also host a state-of-the-art lecture theatre for
scientific lectures, public health forums, and other educational
activities. The 200-seat venue will provide a forum for Canada’s leading
specialists, local and visiting speakers, to share their knowledge,
collaborate and learn from each other.